ALLO - Wall Street Estimates - Allogene Therapeutics, Inc.

Healthcare - Biotechnology - NASDAQ - US

$ 1.82

-1.09 %

$ 382 M

Market Cap

-1.17

P/E

Price Target Average

943.96%

Revenue Forecast Estimate

1263.03%

EBIT Estimate

47.25%

Net Income Estimate

25.86%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets Allogene Therapeutics, Inc.

Wall Street analysts predict an average 1-year price target for ALLO of $19 , with forecasts ranging from a low of $7 to a high of $55 .

ALLO Lowest Price Target Wall Street Target

7 USD 284.62%

ALLO Average Price Target Wall Street Target

19 USD 943.96%

ALLO Highest Price Target Wall Street Target

55 USD 2921.98%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free